Publications by authors named "Antonia Busse"

Claim this Profile
R
Recombination junctions from antibody isotype switching classify immune and DNA repair dysfunction.
Clara Vázquez García, Benedikt Obermayer, Baerbel Keller, Mikhail Lebedin, Christoph Ratswohl, Antonia Busse

Nat Commun· December 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
A CD22-Specific T-Cell Receptor Enables Effective Adoptive T-Cell Therapy for B-cell malignancies.
Simone Rhein, Neşe Çakmak-Görür, Corinna Grunert, Sarah Hayder Jalal Al-Tabatabaee, Nazli Serin, Antonia Busse

Blood· October 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
Teclistamab-induced rapid remission in refractory Anti-Jo-1 Antisynthetase Syndrome.
Elpida Phithak, Fredrik N Albach, Ioanna Minopoulou, Robert Biesen, Arnd Kleyer, Antonia Busse

Ann Rheum Dis· October 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
A phase I study of MAGE-A1-targeted T1367 T-cell receptorbased cell therapy in patients with advanced multiple myeloma.
Josefine Krüger, Matthias Obenaus, Igor Wolfgang Blau, Dana Hoser, Martin Vaegler, Antonia Busse

Haematologica· January 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
Target Selection for T-Cell Therapy in Epithelial Ovarian Cancer: Systematic Prioritization of Self-Antigens.
Paul Schossig, Ebru Coskun, Ruza Arsenic, David Horst, Jalid Sehouli, Antonia Busse

Int J Mol Sci· January 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Activated SUMOylation restricts MHC class I antigen presentation to confer immune evasion in cancer.
Uta M Demel, Marlitt Böger, Schayan Yousefian, Corinna Grunert, Le Zhang, Antonia B Busse

J Clin Invest· May 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Isolation of Neoantigen-Specific Human T Cell Receptors from Different Human and Murine Repertoires.
Corinna Grunert, Gerald Willimsky, Caroline Anna Peuker, Simone Rhein, Leo Hansmann, Antonia Busse

Cancers (Basel)· April 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
Treatment with ribociclib shows favourable immunomodulatory effects in patients with hormone receptor-positive breast cancer-findings from the RIBECCA trial.
Caroline A Peuker, Sarvenaz Yaghobramzi, Corinna Grunert, Luisa Keilholz, Enio Gjerga, Antonia Busse

Eur J Cancer· February 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Correction to: Cancer testis antigen Cyclin A1 harbors several HLA‑A*02:01‑restricted T cell epitopes, which are presented and recognized in vivo.
Anja Tatjana Teck, Sabrina Urban, Petra Quass, Annika Nelde, Heiko Schuster, Antonia Busse

Cancer Immunol Immunother· October 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
H
High-affinity T-cell receptor specific for MyD88 L265P mutation for adoptive T-cell therapy of B-cell malignancies.
Özcan Çınar, Bernadette Brzezicha, Corinna Grunert, Peter Michael Kloetzel, Christin Beier, Antonia Busse

J Immunother Cancer· July 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
L
Long-term in vitro expansion ensures increased yield of central memory T cells as perspective for manufacturing challenges.
Stefanie Herda, Andreas Heimann, Benedikt Obermayer, Elisa Ciraolo, Stefanie Althoff, Antonia Busse

Int J Cancer· June 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Adaptive T-cell immunity controls senescence-prone MyD88- or CARD11-mutant B-cell lymphomas.
Maurice Reimann, Jens Schrezenmeier, Paulina Richter-Pechanska, Anna Dolnik, Timon Pablo Hick, Antonia Busse

Blood· May 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Immunoprofiling in Neuroendocrine Neoplasms Unveil Immunosuppressive Microenvironment.
Antonia Busse, Liliana H Mochmann, Christiane Spenke, Ruza Arsenic, Franziska Briest

Cancers (Basel)· November 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Efficiency of the four proteasome subtypes to degrade ubiquitinated or oxidized proteins.
Joanna Abi Habib, Etienne De Plaen, Vincent Stroobant, Dusan Zivkovic, Marie-Pierre Bousquet, Antonia Busse

Sci Rep· September 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Cancer testis antigen Cyclin A1 harbors several HLA-A*02:01-restricted T cell epitopes, which are presented and recognized in vivo.
Anja Tatjana Teck, Sabrina Urban, Petra Quass, Annika Nelde, Heiko Schuster, Antonia Busse

Cancer Immunol Immunother· July 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
SigsPack, a package for cancer mutational signatures.
Franziska Schumann, Eric Blanc, Clemens Messerschmidt, Thomas Blankenstein, Antonia Busse

BMC Bioinformatics· September 2019

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
W
What Does the Pipeline Promise about Upcoming Biosimilar Antibodies in Oncology?
Antonia Busse, Diana Lüftner

Breast Care (Basel)· March 2019

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
F
Favorable prognostic influence of T-box transcription factor Eomesodermin in metastatic renal cell cancer patients.
Anastasia Dielmann, Anne Letsch, Anika Nonnenmacher, Kurt Miller, Ulrich Keilholz, Antonia Busse

Cancer Immunol Immunother· February 2016

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Characterization of small spheres derived from various solid tumor cell lines: are they suitable targets for T cells?
Antonia Busse, Anne Letsch, Alberto Fusi, Anika Nonnenmacher, David Stather

Clin Exp Metastasis· August 2013

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Analysis of surrogate gene expression markers in peripheral blood of melanoma patients to predict treatment outcome of adjuvant pegylated interferon alpha 2b (EORTC 18991 side study).
Antonia Busse, Jérôme Rapion, Alberto Fusi, Stefan Suciu, Anika Nonnenmacher

Cancer Immunol Immunother· July 2013

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
In vitro effects of perifosine, bortezomib and lenalidomide against hematopoietic progenitor cells from healthy donors.
Martin Schmidt-Hieber, Robert Dabrowski, Babette Aicher, Philipp Lohneis, Antonia Busse

Invest New Drugs· August 2012

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
W
Wilms' tumor protein 1 (WT1) peptide vaccination in AML patients: predominant TCR CDR3β sequence associated with remission in one patient is detectable in other vaccinated patients.
Sebastian Ochsenreither, Alberto Fusi, Anne Geikowski, David Stather, Antonia Busse

Cancer Immunol Immunother· March 2012

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Immunomodulatory effects of sorafenib on peripheral immune effector cells in metastatic renal cell carcinoma.
Antonia Busse, Anne Marie Asemissen, Anika Nonnenmacher, Floriane Braun, Sebastian Ochsenreither

Eur J Cancer· March 2011

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
"
"Wilms Tumor Protein 1" (WT1) peptide vaccination-induced complete remission in a patient with acute myeloid leukemia is accompanied by the emergence of a predominant T-cell clone both in blood and bone marrow.
Sebastian Ochsenreither, Alberto Fusi, Antonia Busse, Sandra Bauer, Carmen Scheibenbogen

J Immunother· January 2011

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Systemic immune tuning in renal cell carcinoma: favorable prognostic impact of TGF-β1 mRNA expression in peripheral blood mononuclear cells.
Antonia Busse, AnneMarie Asemissen, Anika Nonnenmacher, Sebastian Ochsenreither, Alberto Fusi

J Immunother· January 2011

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis